Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment
The patient-reported outcomes (PROs) of the phase 3 NRG Oncology clinical trial RTOG 0815 comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT combined with short-term (6 months) androgen deprivation therapy ...
Apr 28, 2023
0
2